Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases.

MLA

Ma, Suzanne M., et al. “Optimization of a Heterologous Mevalonate Pathway through the Use of Variant HMG-CoA Reductases.” Metabolic Engineering, vol. 13, no. 5, Sept. 2011, pp. 588–97. EBSCOhost, https://doi.org/10.1016/j.ymben.2011.07.001.

APA

Ma, S. M., Garcia, D. E., Redding-Johanson, A. M., Friedland, G. D., Chan, R., Batth, T. S., Haliburton, J. R., Chivian, D., Keasling, J. D., Petzold, C. J., Lee, T. S., & Chhabra, S. R. (2011). Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases. Metabolic Engineering, 13(5), 588–597. https://doi.org/10.1016/j.ymben.2011.07.001

Chicago

Ma, Suzanne M, David E Garcia, Alyssa M Redding-Johanson, Gregory D Friedland, Rossana Chan, Tanveer S Batth, John R Haliburton, et al. 2011. “Optimization of a Heterologous Mevalonate Pathway through the Use of Variant HMG-CoA Reductases.” Metabolic Engineering 13 (5): 588–97. doi:10.1016/j.ymben.2011.07.001.